Response criteria for phase III studies of superficial bladder cancer.
D002278:Carcinoma in Situ / Q000628:therapy; D002986:Clinical Trials as Topic; D006801:Humans; D009364:Neoplasm Recurrence, Local; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*